Costs incurred related to discontinuance of a product line.

No definition available.

Name:	ango_CostsOfProductLineDiscontinuance
Namespace Prefix:	ango_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of gain (loss) recognized in earnings related to the sale of a product line.

+ References

No definition available.

+ Details

Name:	ango_GainLossOnSaleOfProductLine
Namespace Prefix:	ango_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Litigation costs.

+ References

No definition available.

+ Details

Name:	ango_LitigationCosts
Namespace Prefix:	ango_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	ango_QuarterlyInformationAdditionalTextualAbstract
Namespace Prefix:	ango_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	ango_QuarterlyInformationTextualAbstract
Namespace Prefix:	ango_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 25

-Paragraph 23

-URI http://asc.fasb.org/extlink&oid=34752592&loc=d3e1043-128460

+ Details

Name:	us-gaap_BusinessCombinationAcquisitionRelatedCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessCombinationIntegrationRelatedCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 5.P.4(b))

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 420

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 5.P.3)

-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140864-122747

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section P

-Subsection 3, 4

+ Details

Name:	us-gaap_BusinessExitCosts1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_BusinessAcquisitionAxis=ango_ClinicalDevicesB.V.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=ango_NavilystMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=ango_VortexAndMicrosulisMedicalLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=ango_VortexMedicalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationCaseAxis=ango_VortexMedicalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Quarterly Information (unaudited) (Details Textual) (USD $)	3 Months Ended								12 Months Ended
	Feb. 28, 2013	Nov. 30, 2012	May 31, 2014	Feb. 28, 2014	Nov. 30, 2013	Aug. 31, 2013	May 31, 2013	Aug. 31, 2012	May 31, 2014	May 31, 2013
Quarterly Information (Additional Textual) [Abstract]
Transaction and related costs, UK facility	$ 920,000us-gaap_BusinessExitCosts1	$ 476,000us-gaap_BusinessExitCosts1
Navilyst [Member]
Quarterly Information (Textual) [Abstract]
Acquisition of related cost\transaction and related costs	1,300,000	1,700,000	1,300,000	1,400,000	1,600,000	1,200,000	2,100,000	2,200,000
Consolidation charges			400,000	1,000,000
Litigation related costs			1,100,000		800,000		580,000
Quarterly Information (Additional Textual) [Abstract]
Costs related to the discontinuance of product line	1,600,000
Transaction and related costs, UK facility							717,000	337,000
Vortex Medical [Member]
Quarterly Information (Textual) [Abstract]
Acquisition of related cost\transaction and related costs									162,000	645,000
Litigation related costs		425,000
Quarterly Information (Additional Textual) [Abstract]
Gain (loss) on sale of product line		770,000
Clinical Devices, B.V. [Member]
Quarterly Information (Textual) [Abstract]
Acquisition of related cost\transaction and related costs						300,000
Vortex and Microsulis Medical Ltd [Member]
Quarterly Information (Textual) [Abstract]
Acquisition of related cost\transaction and related costs	414,000
Litigation related costs	901,000
Vortex Medical [Member]
Quarterly Information (Textual) [Abstract]
Acquisition of related cost\transaction and related costs		$ 325,000